Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1985 Apr;48(1):62–72. doi: 10.1128/iai.48.1.62-72.1985

Purification and characterization of an extracellular cytolysin produced by Vibrio vulnificus.

L D Gray, A S Kreger
PMCID: PMC261915  PMID: 3980095

Abstract

An extracellular cytolytic toxin produced by the halophilic bacterium Vibrio vulnificus was isolated free of detectable contamination with medium constituents and other bacterial products by sequential ammonium sulfate precipitation, gel filtration with Sephadex G-75, hydrophobic interaction chromatography with phenyl-Sepharose CL-4B, and isoelectric focusing in an ethylene glycol density gradient. The cytolysin is a heat-labile, hydrophobic protein that is inhibited by large amounts of cholesterol, is partially inactivated by proteases and trypan blue, has a molecular weight (estimated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and by amino acid analysis) of ca. 56,000, and has an isoelectric point of ca. 7.1. The first 10 amino-terminal amino acid residues of the cytolysin are Gln-Glu-Tyr-Val-Pro-Ile-Val-Glu-Lys-Pro. Lysis of mouse erythrocytes by the purified cytolysin is a multi-hit, at least two-step process consisting of a temperature-independent, toxin-binding step, followed by a temperature-dependent, membrane-perturbation step(s). In addition to possessing cytolytic activity against erythrocytes from 17 animal species and against Chinese hamster ovary cells in tissue culture, the purified cytolysin preparation was lethal for mice (ca. 3 micrograms/kg, intravenous 50% lethal dose) and had vascular permeability factor activity in guinea pig skin.

Full text

PDF
62

Images in this article

64Image
on p.64
65Image
on p.65
66Image
on p.66
67Image
on p.67
68Image
on p.68
68Image
on p.68

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alouf J. E., Jolivet-Reynaud C. Purification and characterization of Clostridium perfringens delta-toxin. Infect Immun. 1981 Feb;31(2):536–546. doi: 10.1128/iai.31.2.536-546.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BERNHEIMER A. W., SCHWARTZ L. L. Isolation and composition of staphylococcal alpha toxin. J Gen Microbiol. 1963 Mar;30:455–468. doi: 10.1099/00221287-30-3-455. [DOI] [PubMed] [Google Scholar]
  3. Blake P. A., Weaver R. E., Hollis D. G. Diseases of humans (other than cholera) caused by vibrios. Annu Rev Microbiol. 1980;34:341–367. doi: 10.1146/annurev.mi.34.100180.002013. [DOI] [PubMed] [Google Scholar]
  4. Bowdre J. H., Poole M. D., Oliver J. D. Edema and hemoconcentration in mice experimentally infected with Vibrio vulnificus. Infect Immun. 1981 Jun;32(3):1193–1199. doi: 10.1128/iai.32.3.1193-1199.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  6. Craig D. B., Stevens D. L. Halophilic Vibrio sepsis. South Med J. 1980 Sep;73(9):1285–1287. doi: 10.1097/00007611-198009000-00048. [DOI] [PubMed] [Google Scholar]
  7. Fernandez C. R., Pankey G. A. Tissue invasion by unnamed marine vibrios. JAMA. 1975 Sep 15;233(11):1173–1176. [PubMed] [Google Scholar]
  8. Hewick R. M., Hunkapiller M. W., Hood L. E., Dreyer W. J. A gas-liquid solid phase peptide and protein sequenator. J Biol Chem. 1981 Aug 10;256(15):7990–7997. [PubMed] [Google Scholar]
  9. Hollis D. G., Weaver R. E., Baker C. N., Thornsberry C. Halophilic Vibrio species isolated from blood cultures. J Clin Microbiol. 1976 Apr;3(4):425–431. doi: 10.1128/jcm.3.4.425-431.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hugli T. E., Moore S. Determination of the tryptophan content of proteins by ion exchange chromatography of alkaline hydrolysates. J Biol Chem. 1972 May 10;247(9):2828–2834. [PubMed] [Google Scholar]
  11. Hunkapiller M. W., Hood L. E. Analysis of phenylthiohydantoins by ultrasensitive gradient high-performance liquid chromatography. Methods Enzymol. 1983;91:486–493. doi: 10.1016/s0076-6879(83)91045-5. [DOI] [PubMed] [Google Scholar]
  12. Inoue K., Akiyama Y., Kinoshita T., Higashi Y., Amano T. Evidence for a one-hit theory in the immune bactericidal reaction and demonstration of a multi-hit response for hemolysis by streptolysin O and Clostridium perfringens theta-toxin. Infect Immun. 1976 Feb;13(2):337–344. doi: 10.1128/iai.13.2.337-344.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Johnson M. K., Boese-Marrazzo D. Production and properties of heat-stable extracellular hemolysin from Pseudomonas aeruginosa. Infect Immun. 1980 Sep;29(3):1028–1033. doi: 10.1128/iai.29.3.1028-1033.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Johnson M. K. Properties of purified pneumococcal hemolysin. Infect Immun. 1972 Nov;6(5):755–760. doi: 10.1128/iai.6.5.755-760.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kreger A. S. Cytolytic activity and virulence of Vibrio damsela. Infect Immun. 1984 May;44(2):326–331. doi: 10.1128/iai.44.2.326-331.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kreger A. S., Gray L. D. Purification of Pseudomonas aeruginosa proteases and microscopic characterization of pseudomonal protease-induced rabbit corneal damage. Infect Immun. 1978 Feb;19(2):630–648. doi: 10.1128/iai.19.2.630-648.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kreger A. S., Gray L. D., Testa J. Protection of mice against Vibrio vulnificus disease by vaccination with surface antigen preparations and anti-surface antigen antisera. Infect Immun. 1984 Sep;45(3):537–543. doi: 10.1128/iai.45.3.537-543.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kreger A., DeChatelet L., Shirley P. Interaction of Vibrio vulnificus with human polymorphonuclear leukocytes: association of virulence with resistance to phagocytosis. J Infect Dis. 1981 Sep;144(3):244–248. doi: 10.1093/infdis/144.3.244. [DOI] [PubMed] [Google Scholar]
  19. Kreger A., Lockwood D. Detection of extracellular toxin(s) produced by Vibrio vulnificus. Infect Immun. 1981 Aug;33(2):583–590. doi: 10.1128/iai.33.2.583-590.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  21. Marchlewicz B. A., Duncan J. L. Lysis of erythrocytes by a hemolysin produced by a group B Streptococcus sp. Infect Immun. 1981 Dec;34(3):787–794. doi: 10.1128/iai.34.3.787-794.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Oberley T. D., Duncan J. L. Characteristics of streptolysin O action. Infect Immun. 1971 Dec;4(6):683–687. doi: 10.1128/iai.4.6.683-687.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Okumura T., Kimura S., Saito K. A novel purification procedure for Penicillium notatum phospholipase B and evidence for a modification of phospholipase B activity by the action of an endogenous protease. Biochim Biophys Acta. 1980 Feb 22;617(2):264–273. [PubMed] [Google Scholar]
  24. Poole M. D., Oliver J. D. Experimental pathogenicity and mortality in ligated ileal loop studies of the newly reported halophilic lactose-positive Vibrio sp. Infect Immun. 1978 Apr;20(1):126–129. doi: 10.1128/iai.20.1.126-129.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Reiser R. F., Robbins R. N., Noleto A. L., Khoe G. P., Bergdoll M. S. Identification, purification, and some physicochemical properties of staphylococcal enterotoxin C3. Infect Immun. 1984 Sep;45(3):625–630. doi: 10.1128/iai.45.3.625-630.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Sanai Y., Morihara K., Tsuzuki H., Homma J. Y., Kato I. Proteolytic cleavage of exotoxin A from Pseudomonas aeruginosa: formation of an ADP-ribosyltransferase active fragment by the action of Pseudomonas elastase. FEBS Lett. 1980 Oct 20;120(1):131–134. doi: 10.1016/0014-5793(80)81063-5. [DOI] [PubMed] [Google Scholar]
  27. Simpson L. M., Oliver J. D. Siderophore production by Vibrio vulnificus. Infect Immun. 1983 Aug;41(2):644–649. doi: 10.1128/iai.41.2.644-649.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Smith G. C., Merkel J. R. Collagenolytic activity of Vibrio vulnificus: potential contribution to its invasiveness. Infect Immun. 1982 Mar;35(3):1155–1156. doi: 10.1128/iai.35.3.1155-1156.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Testa J., Daniel L. W., Kreger A. S. Extracellular phospholipase A2 and lysophospholipase produced by Vibrio vulnificus. Infect Immun. 1984 Aug;45(2):458–463. doi: 10.1128/iai.45.2.458-463.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Thorsteinsson S. B., Minuth J. N., Musher D. M. Clinical manifestations of halophilic non-cholera Vibrio infections. Lancet. 1974 Nov 30;2(7892):1283–1284. doi: 10.1016/s0140-6736(74)90141-x. [DOI] [PubMed] [Google Scholar]
  31. Tison D. L., Kelly M. T. Vibrio species of medical importance. Diagn Microbiol Infect Dis. 1984 Sep;2(4):263–276. doi: 10.1016/0732-8893(84)90057-9. [DOI] [PubMed] [Google Scholar]
  32. Weber K., Pringle J. R., Osborn M. Measurement of molecular weights by electrophoresis on SDS-acrylamide gel. Methods Enzymol. 1972;26:3–27. doi: 10.1016/s0076-6879(72)26003-7. [DOI] [PubMed] [Google Scholar]
  33. Wickboldt L. G., Sanders C. V. Vibrio vulnificus infection. Case report and update since 1970. J Am Acad Dermatol. 1983 Aug;9(2):243–251. doi: 10.1016/s0190-9622(83)80357-0. [DOI] [PubMed] [Google Scholar]
  34. Zide N., Davis J., Ehrenkranz N. J. Fulminating vibrio parahemolyticus septicemia. A syndrome of erythemia multiforme, hemolytic anemia, and hypotension. Arch Intern Med. 1974 Mar;133(3):479–481. doi: 10.1001/archinte.133.3.479. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES